Dr. Modur is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
480 Arsenal St
Watertown, MA 02472Phone+1 617-455-2296- Is this information wrong?
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1997 - 2002
Karnataka Institute of Medical ScienceClass of 1990
Certifications & Licensure
MO State Medical License 2010 - 2025- American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- 1 citationsNovel read through agent: ZKN-0013 demonstrates efficacy in APCmodel of familial adenomatous polyposis.Martin R Graf, Shruti Apte, Esteban Terzo, Simran Padhye, Shuhao Shi, Megan K Cox, Roger B Clark, Vijay Modur, Vasudeo Badarinarayana> ;Journal of Molecular Medicine. 2023 Apr 1
- 7 citationsVenglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase...Ronald T Gansevoort, Ali Hariri, Pascal Minini, Arlene B Chapman, Shigeo Horie, Bertrand Knebelmann, Michal Mrug, Albert C M Ong, York P C Pei, Vicente E Torres, Vijay...> ;American Journal of Kidney Diseases. 2023 May 1
- 10 citationsVenglustat, an orally administered glucosylceramide synthase inhibitor: Assessment over 3 years in adult males with classic Fabry disease in an open-label phase 2 stud...Patrick B Deegan, Ozlem Goker-Alpan, Tarekegn Geberhiwot, Robert J Hopkin, Elena Lukina, Anna Tylki-Szymanska, Atef Zaher, Charlotte Sensinger, Sebastiaan J M Gaemers,...> ;Molecular Genetics and Metabolism. 2023 Feb 1
- Join now to see all
Press Mentions
ELX-02 Lowers Sweat Chloride in Patients with G542X Mutation, Trials FindNovember 19th, 2021- Eloxx Pharmaceuticals Appoints Chief Medical OfficerSeptember 8th, 2021
- Chutes & Ladders—with Liang Set to Retire, BeiGene Names New Chief Financial OfficerApril 2nd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
